Data Innovation Consumers
Turn healthcare real-world data into insights that drive smarter decisions.
Bridging the gap between fragmented data and actionable insights
AI/ML, analytics, and consulting teams are increasingly turning to real-world patient data to train models, evaluate opportunities, and uncover new insights. While teams can access more healthcare data than ever, it’s often fragmented, incomplete, or difficult to consolidate, making model development, advanced analytics, and strategic insights harder than they should be. Power these workflows with harmonized, longitudinal healthcare data.
Solving the Barriers to Modern Healthcare AI and Analytics
Fragmented, siloed data across sources makes it hard to build complete, longitudinal patient views, especially when unstructured clinical data are involved.
Teams often lack the infrastructure to build and maintain scalable, longitudinal datasets, limiting their ability to generate timely, actionable insights.
Stakeholders expect rapid insights, even as data volumes grow and models require continuous retraining on updated data.
A Unified Healthcare Data Asset
Driving analytics and strategic decisions with high-fidelity data.
Powering Data-Driven Decisions in Healthcare
TriNetX delivers large-scale, longitudinal healthcare data sourced directly from its global network of healthcare organizations. The quality is far richer and more detailed than claims-based or aggregated datasets, powering more accurate models, faster analytics, and higher-confidence strategic decisions.
Enables a more complete understanding of disease severity, patient journeys, and treatment patterns, supporting more accurate modeling and insights.
Data from partnering healthcare organizations is refreshed every 3 to 4 weeks, helping teams keep analyses up to date and retrain models as datasets evolve.
Flexible dataset definition supports specific disease areas or pan-therapeutic analyses, allowing teams to adjust to evolving models, questions, and priorities.
Track patient journeys over time, across markets and care settings, supporting analyses that require continuity rather than isolated snapshots.
Supports predictive modeling and advanced analytics, delivering scalable, full-picture insights across patient populations, outcomes, and treatment patterns.
Fits seamlessly into existing analytics and modeling workflows, enabling teams to generate insights without retooling processes.
How Teams are Leveraging TriNetX Data
See how teams can apply unified, longitudinal datasets to generate insights, train models, and support high-stakes decision-making.
Longitudinal patient data can be used to train and validate predictive models, thereby improving accuracy and capturing disease progression beyond what fragmented datasets can.
Structured and unstructured clinical data can be evaluated to uncover real-world outcomes, supporting evidence-backed insights for research or market decisions.
Integrated datasets can be leveraged to evaluate pipeline opportunities, assess population trends, and identify emerging risks.
Diverse data sources can be consolidated into a unified view, enabling faster analyses and model iteration while keeping insights current as data evolves.
Data can be scoped for specific diseases or broader therapeutic areas, supporting ad hoc queries and evolving research questions as priorities shift.
TriNetX offers multiple data and analytics solutions to support different teams, workflows, and objectives. Working with us is designed to be straightforward: you define the questions you need to answer, the data you need, and how you want to work with it. We help align the right solution to your goals.
Solutions for Data Innovation Consumers
From infrastructure gaps to scalable insights.
Define, explore, and analyze real-world data from nearly 300 million patients worldwide on our easy-to-use, web-based platform.
Unlock deeper insights with fine-grained, date-stamped datasets from more than 150 million patients around the world.
Want to learn more?
Explore our insights
Children’s Mercy is focused on expanding access to de-identified clinical data in support of its research mission: equipping investigators with tools and resources that help strengthen studies, accelerate insights, and ultimately improve care for children.
TriNetX Chief Scientific Officer Jeffrey Brown, PhD, and Miguel Hernán, MD, PhD, ScD, Director of CAUSALab at Harvard, walk through a practical framework for designing rigorous Real-World Data studies for causal inference.
A peer-reviewed study evaluating an AI model for hepatocellular carcinoma (HCC)
risk prediction highlights that AI success in global clinical development depends on access to scalable, standardized, and federated real-world data infrastructure.
Most clin ops leaders know intuitively that their AI results have been inconsistent. Fewer know exactly which part of the data foundation is responsible, or what specific questions to ask to find out.
Contact Us
General inquiries
Have a question about our platform, need support, or simply want to learn more about what we do?
Please share your details and we’ll get back to you soon.
"*" indicates required fields
Book a demo - TriNetX LIVE™
Book a demo of our real-world data platform for your clinical research.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
